MarketResearch.biz delivers in-depth insights on the global antacid market in its upcoming report titled, “Global Antacid Market Trends, Applications, Analysis, Growth, and Forecast: 2018 to 2027”. The global antacid market is estimated to register a CAGR of XXX% in terms of value during forecast period 2018–2027. The report offers in-depth insights, revenue details, and other vital information regarding the target market, and the various trends, drivers, restraints, opportunities, and threats till 2027. The report offers insightful and detailed information regarding the various key players operating in the market, their financials, supply chain trends, technological innovations, key developments, apart from future strategies, acquisitions & mergers, and market footprint. The global antacid market report has been segmented on the basis of drug class, formulation type, distribution channel and region.
Antacids are the substances which reduce gastric acidity, resulting in increase in the pH of stomach and duodenum. Gastric acidity occurs due to excessive secretion of HCl in stomach. Antacids are the group of drugs used to neutralize the excess gastric HCl associated with gastritis or peptic ulcer. Antacids are oral medicines which is administered to get relieve from heartburn, sour stomach, or acid indigestion. Antacids medicines generally include aluminium hydroxide, magnesium carbonate and magnesium trisilicate. These are available in various brand names and forms such as tablets and liquids. According to World Health Organization 2017, more than $10 billion is being spent worldwide each year on antacids.
The factor driving the growth of global antacid market are changing dietary habits, growing geriatric population around world, sedentary lifestyle, increasing incidence of gastroesophageal reflux disease(GERD). In addition, increasing consumption of foods such as fried or fatty foods, citrus, and chocolate, coffee, carbonated beverages etc. which increase the gastric HCl content in stomach is resulting in adoption of antacid, thereby boosting growth of the market of antacid globally. Sometimes self-medication of antacid without proper knowledge or advise may lead to adverse effects and is the factor expected to challenge growth of the global antacid market.
Natural plants extract to combat stomach acidity are now-a-days used to manufactured antacid drug formulations. The extracts from herbal plants are being used worldwide for treatment of acidity related problems. According to World Gastroenterology Organization, the prevalence of GERD is increasing worldwide and ranges from nearly 2.5% to 6.6% in Eastern Asia and nearly 13.8% to 25.8% in North America.
North America market is expected to dominate the global antacid market owing to increasing incidence of gastroesophageal reflux disease(GERD). According to the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), in US, approximately 20 percent of the population suffer from GERD. Asia Pacific is an emerging market for antacid due to increasing aging population. As per statistics of the Asian Development Bank, the population of individuals above the age of 60 years in Asia is projected to touch 923 million by 2050.
Global Antacid Market Segmentation:
On the basis of drug class:
- Proton pump inhibitors
- H2 antagonist
- Acid neutralizers
On the basis of formulation:
On the basis of distribution channel:
- Hospital pharmacy
- Retail pharmacy
- Others (including online platform, specialty store, grocers, general stores etc.)
On the basis of region:
- North America
- Asia Pacific
- Latin America
- Middle East & Africa
Attribute Report Details Market Size Ask For Market Size Growth Rate Ask For Growth Rate Key Companies Ask For Companies Report Coverage Revenue analysis, Competitive landscape, Key company analysis, Market Trends, Key segments, Distribution Channel, Market Dynamics, COVID-19 Impact Analysis and more… Historical Data Period 2015-2020 Base Year 2022 Forecast Period 2022-2031 Region Scope North America, Europe, Asia-Pacific, South America, Middle East & Africa Country Scope United States, Canada and Mexico, Germany, France, UK, Russia and Italy, China, Japan, Korea, India and Southeast Asia, Brazil, Argentina, Colombia etc.Saudi Arabia, UAE, Egypt, Nigeria and South Africa Revenue in US$ Mn
- AstraZeneca plc.
- Bayer AG
- Boehringer Ingelheim GmbH
- Reddy’s Laboratories Ltd.
- GlaxoSmithKline plc.
- Pfizer Inc.
- Procter & Gamble Company
- Sun Pharmaceuticals Ltd.
- Takeda Pharmaceutical Company Ltd.
- Sanofi-Aventis LLC
Request for TOC
Why Choose Us
- 360 Degree Approach
- Growth Consulting
- 24/7 Research Support
- Comprehensive-Level of Customization
- Comprehensive-Level of Customization
- Competitive Intelligence
- Single-Country/ Region Intelligence
- Post-Sale Service Assistance
- Access to Lead Analysts
- Available in PDF, Excel, Word/ PPT
Request for Customization
Don't just take our word. We are trusted by these great companies!